Single-Port Sleeve Gastrectomy Compared With Conventional Laparoscopic Sleeve Gastrectomy: 5-Year Follow-up of Weight Loss, Comorbidity Resolution, and Cost
| Autor: | Walid El Ansari, Davit Sargsyan, Mohsen Karam, Moamena El Matbouly, Nesreen Khidir, Michel Gagner, Mohammed bin Saif Al-Kuwari, Helmuth T. Billy, Moataz Bashah |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Sleeve gastrectomy genetic structures medicine.medical_treatment Comorbidity complex mixtures Body Mass Index 03 medical and health sciences 0302 clinical medicine Port (medical) Weight loss Gastrectomy Weight Loss medicine Humans Retrospective Studies Spider business.industry Cosmesis medicine.disease Surgery Obesity Morbid Treatment Outcome nervous system 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Laparoscopy medicine.symptom Complication business Body mass index Follow-Up Studies |
| Zdroj: | Surgical innovation. 27(3) |
| ISSN: | 1553-3514 |
| Popis: | Background. The Single-Port Instrument Delivery Extended Reach (SPIDER) surgical system is a safe revolutionary technology that defeated difficulties of single-incision surgery. We assessed the long-term outcomes of SPIDER sleeve gastrectomy (SPIDER SG) versus conventional laparoscopic sleeve gastrectomy (LSG) in morbidly obese patients. Methods. Retrospective review of patients who underwent SPIDER SG or LSG in our center matched by the date of surgery (2012-2013). We reviewed weight loss results up to 5 years, complication rates, procedure and hospitalization durations, financial cost, and effect on comorbidities. Results. Patients underwent 200 SPIDER SG and 220 LSG. At baseline, SPIDER SG versus LSG patients had a mean body mass index of 43.8 ± 5.6 and 48.6 ± 8.1 kg/m2, respectively. At 1 year, both groups had comparable percentage of excess weight loss (%EWL). At 5 years, SPIDER SG had %EWL of 54.6 ± 24.8 compared with 57.8 ± 29.9 in LSG ( P = .4). Nine SPIDER SG (4.5%) required conversion to LSG. Complications occurred in both groups: 4% versus 4.1% ( P = .95). At 2-year follow-up, diabetes mellitus was reversed in 43% of SPIDER SG and 62% LSG. Despite a shorter hospital stay in SPIDER SG, the total cost was significantly higher ($2 041 477) compared with LSG ($1 773 834). The mean score of scar satisfaction was significantly more in SPIDER SG. Conclusions. SPIDER SG was safe with long-term effects on weight loss comparable to LSG. Despite the higher cost of SPIDER SG, a shorter hospital stay and better cosmesis were observed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|